Search
forResearch 10 of 1000+
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Under Development JAK Inhibitors for Dermatologic Diseases
- Jak inhibitors in the treatment of alopecia areata - a literature review
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- The Role of Janus Kinase Inhibitors in Dermatology
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
Learn 2 of 4
All learn results →Community
— no results
Try a deeper search in community →